Optical Tomography in Prostate Cancer
Prostate Cancer
About this trial
This is an interventional device feasibility trial for Prostate Cancer focused on measuring Diffuse Optical Tomography
Eligibility Criteria
Inclusion Criteria:
- Men 18 years of age or older scheduled for transrectal prostate biopsy or radical prostatectomy at Columbia University Medical Center
- Signing consent for study imaging procedure and analysis of prostate biopsy
Exclusion criteria:
- Patients failing to meet the inclusion criteria
- Contraindication for magnetic resonance imaging
Sites / Locations
- Columbia University Medical Center
Arms of the Study
Arm 1
Arm 2
Other
Other
Men diagnosed with prostate cancer
Men without prostate cancer
This group will include men over the age of 18 suspected of having prostate cancer who will undergo an ultrasound guided transrectal prostate biopsy. Each study participant will undergo a standard prostate biopsy and DOT imaging using the Diffuse Optical Tomography (DOT) System will be performed at the same time.
This group will include men who do not have prostate cancer. Each study participant will undergo a standard prostate biopsy and DOT imaging using the Diffuse Optical Tomography (DOT) System will be performed at the same time.